Dermatology, Rheumatology, and the Space Between

Cutaneous lupus is seen as a dermatologic disease, but not always a dermatology-only disease. In this topical conversation, Saakshi Khattri, MD and Joseph Merola, MD, MMSc, discuss how dermatology clinicians can approach CLE with more confidence, from distinguishing skin-limited disease from presentations that warrant systemic evaluation, to knowing when rheumatology should enter the conversation.

The discussion moves beyond recognition alone and into the decisions that shape long-term outcomes: what to ask at the first visit, which baseline labs may help risk-stratify patients, why urinalysis should not be overlooked, and when active skin disease should prompt earlier escalation. Throughout, the conversation returns to a central point for dermatology—CLE is not “just skin.” It is a potentially scarring disease in which delayed or undertreated inflammation can leave patients with pigmentary change, alopecia, and irreversible damage.

As emerging targeted therapies begin to shift the conversation, this episode looks at how clinicians can define control more proactively and take a more active role in the care of patients with CLE.